Company Presentation • 23 Sep 2026 22:00
R&D Day 2026
Company Presentation • 07 Jul 2026 00:00
Investor presentation
Company Presentation • 26 Jun 2026 00:00
Life Sciences Virtual Investor Forum
No more presentations
𝛼SK or SearchENTITY
Imunon (IMNN US)
Imunon (IMNN US)
22
Analysis
Health Care • United States
IMUNON, Inc. operates as a clinical stage biotechnology company. The Company focuses on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON serves customers worldwide.
morex